Molecular Partners AG
MOLN | SW
Overview
Corporate Details
- ISIN(s):
- CH0256379097 (+1 more)
- LEI:
- 875500AXMLDAZ4D21744
- Country:
- Switzerland
- Address:
- Wagistrasse 14, 8952 Schlieren
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
We are pioneers: inventors and developers of an entirely new class of therapeutics. As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases. Our long-term strategy leverages our in-house DARPin design and development expertise combined with the capabilities of world-class partners to deliver a broad pipeline of innovative therapeutics.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2020-07-07 07:25 |
Regulatory News Service
Molecular Partners AG: Molecular Partners Successfully Completes the Launch of …
|
English | 17.3 KB | |
| 2020-04-19 23:15 |
Regulatory News Service
Molecular Partners Initiates Anti-COVID-19 Therapeutic Program Leveraging Multi…
|
English | 12.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-09 | N/A | Executive member | Sell | None | 47,784.80 CHF |
| 2024-09-09 | N/A | Executive member | Sell | None | 13,822.40 CHF |
| 2024-04-02 | N/A | Executive member | Sell | None | 243,000.00 CHF |
| 2023-11-01 | N/A | Executive member | Buy | None | 31,760.55 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 2,410,500.00 CHF |
| 2022-02-15 | N/A | Executive member | Sell | None | 1,607,000.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
KANABO GROUP PLC | United Kingdom | KNB | |
|
Karo Pharma AB | Sweden | KARO | |
|
Kinarus Therapeutics Holding AG | Switzerland | KNRS | |
|
Klaria Pharma Holding AB | Sweden | KLAR | |
|
Kolinpharma | Italy | KIP | |
|
Krka | Slovenia | KRKG | |
|
Kyivmedpreparat | Ukraine | KMED | |
|
Labiana S.A. | Spain | LAB | |
|
Labocanna Spolka Akcyjna | Poland | LCN | |
|
Laboratorio Farmaceutico Erfo | Italy | ERFO |